[Federal Register Volume 65, Number 28 (Thursday, February 10, 2000)]
[Notices]
[Pages 6607-6613]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-3062]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Program Announcement 00033]


Childhood Lead Poisoning Prevention Programs (CLPPP); Notice of 
Availability of Funds

A. Purpose

    The Centers for Disease Control and Prevention (CDC) announces the 
availability of fiscal year (FY) 2000 funds for a cooperative agreement 
program for new State and competing continuation State and local 
programs to develop and improve Childhood Lead Poisoning Prevention 
activities which include building Statewide capacity to conduct 
surveillance of blood lead levels in children. This program addresses 
the ``Healthy People 2000'' priority area of Environmental Health.
    The purpose of this program is to provide the impetus for the 
development, implementation, expansion, and evaluation of State and 
local childhood lead poisoning prevention program activities which 
include Statewide surveillance capacity to determine areas at high risk 
for lead exposure. Also, this cooperative agreement is to carry out the 
core public health functions of Assessment, Policy Development, and 
Assurance in childhood lead poisoning prevention programs.
    Funding for this program will be to:
    1. Develop and/or enhance a surveillance system that monitors all 
blood lead levels.
    2. Assure screening of children who are potentially exposed to lead 
and follow-up care for children who are identified with elevated blood 
lead levels (BLLs).
    3. Assure awareness and action among the general public and 
affected professionals in relation to preventing childhood lead 
poisoning.
    4. Expand primary prevention of childhood lead poisoning in high-
risk areas in collaboration with other government and community-based 
organizations.
    As programs shift emphasis from providing direct screening and 
follow-up services to the core public health functions, cooperative 
agreement funds may be used to support and emphasize health department 
responsibilities to screen high risk children and provide appropriate 
follow-up services. This includes improving coalitions and 
partnerships; conducting better and more sophisticated assessments; 
developing and evaluating policies, program performance, and 
effectiveness based on established goals and objectives.

B. Eligible Applicants

    Applicant eligibility is divided into Part A (New Applicants), Part 
B (Competing Continuation), and Part C (Supplemental Funding for 
Alternative Surveillance Assessment/Screening Recommendation 
Evaluation) defined in the following section. In the future, CDC plans 
to shift its program emphasis toward State funding for childhood lead 
poisoning prevention activities. However, the top five metropolitan 
statistical areas (SMSAs)/largest cities will be eligible for direct 
funding for childhood lead poisoning prevention activities 
indefinitely. They are New York City, Los Angeles, Chicago, 
Philadelphia, and Houston.
    Part A: Eligible applicants are State health departments or other 
State health agencies or departments not currently funded by CDC and 
any eligible SMSA not currently receiving direct funding from CDC for 
childhood lead poisoning prevention activities. Also eligible are 
health departments or other official organizational authority (agency 
or instrumentality) of the District of Columbia, the Commonwealth of 
Puerto Rico, any territory or possession of the United States, and all 
federally-recognized Indian tribal governments. Please note: Local 
health departments are not eligible to apply for cooperative agreement 
funding under Part A of this program announcement.
    Applicants encouraged to apply under Part A are: Alaska; Arkansas; 
Georgia; Hawaii; Idaho; Kansas; Kentucky; Mississippi; Nevada; North 
Dakota; Oklahoma; South Dakota; Tennessee; Texas and Wyoming.
    Part B: Eligible applicants are those currently funded by the 
Centers for Disease Control and Prevention whose project period will 
expire June 30, 2000. These applicants are: Alabama; Arizona; 
California; Delaware; Detroit, MI; Houston, TX; Indiana; Iowa; Maine; 
Marion County, IN; Michigan; New Hampshire; Pinellas County, FL; Salt

[[Page 6608]]

Lake City, UT; Virginia and Westchester, NY. In the future, CDC plans 
to shift its program emphasis towards State and large metropolitan 
statistical areas (SMSAs) which includes Houston, TX funding for 
childhood lead poisoning prevention activities. Consequently, local 
applicants eligible for Part B will only receive funding for a two-year 
project period based on satisfactory program performance. These are 
Detroit, MI; Marion County, IN; Pinellas County, FL; Salt Lake City, 
UT; and Westchester, NY.
    Part C: Eligible applicants are those State applicants that apply 
under Part B. Funding under Part C will only be considered if the Part 
B application: (1) Is successful and chosen for funding and (2) has met 
the program requirement of submitting data to CDC's national 
surveillance database.
    Additional information for all State applicants. If a State agency 
applying for grant funds is other than the official State health 
department, written concurrence by the State health department must be 
provided (for example, the State environmental health agency).

C. Availability of Funds

Part A: New Applicants
    Up to $2,500,000 will be available in FY 2000 to fund up to 8 new 
applicants. CDC anticipates that awards for the first budget year will 
range from $75,000 to $800,000.
Part B: Competing Continuations
    Up to $8,000,000 will be available in FY 2000 to fund up to 17 
competing continuation applicants. CDC anticipates that awards for the 
first budget year will range from $75,000 to $1,500,000.
Part C: Supplemental Studies
    Up to $400,000 will be awarded in FY 2000 to fund up to 4 
assessment/evaluation studies with a three-year project period. These 
funds will be awarded to support the development of alternative 
surveillance assessments and/or to conduct evaluation of the impact of 
lead screening recommendations. Awards are expected to range from 
$70,000 to $100,000, with the average award being approximately 
$85,000. Funds will be awarded for assessment/evaluation studies that 
address one of the following:
    1. Alternative Surveillance Assessment--Assessment of lead exposure 
in a jurisdictional population or sub-population using an approach to 
surveillance that differs from the Statewide CBLS system described in 
this announcement.
    2. Screening Recommendation Evaluation--Evaluation of the impact of 
lead screening recommendations on screening for high-risk children.
    Funding for State applicants: To determine the type of program 
activities and the associated level of funding for an individual State 
applicant for Part A or Part B, please refer to the table below. These 
are suggested funding guidelines and should not be regarded as absolute 
funding limits. Addendum 2 in the application package provides an 
explanation of the factors used to develop categorical funding 
recommendations. Addendum 3 provides an explanation of the program 
activities required for each funding category.

Suggested Funding Categories Based on Projected Level of Effort 
Required To Provide Prevention and Surveillance Activies to a State 
Population

Alabama--2
Alaska--3
Arizona--3
Arkansas--2
California*--1
Colorado--3
Connecticut--2
Delaware--3
Florida*--3
Georgia--2
Hawaii--3
Idaho--3
Illinois--1
Indiana*--3
Iowa--2
Kansas--2
Kentucky*--3
Louisiana--2
Maine--3
Maryland--2
Massasschusette--2
Michigan*--2
Minnesota--2
Mississippi--2
Missouri--2
Montana--3
Nebraska--2
Nevada--3
N. Hampshire--3
New Jersey--2
New Mexico--3
New York*--2
N. Carolina--2
North Dakota--3
Ohio--1
Oklahoma--2
Oregon--3
Pennsylvania--1
Rhode Island--2
S. Carolina--2
South Dakota--2
Tennessee--2
Texas*--1
Utah*--3
Vermont--3
Virginia--2
Washington--2
West Virginia--2
Wisconsin--2
Wyoming--3

    *Projected level of effort adjusted to account for currently funded 
locales.

    Funding State Applicants--Part A or Part B: Determine your funding 
category (Category 1, 2, or 3) according to the table below. The range 
and average of awards for each funding category follows:

Category 1: $800,000-$1,500,000, average award $1,000,000
Category 2: $250,000-$800,000, average award $520,000
Category 3: $75,000-$250,000, average award $150,000

    Awards for Local Applicants (under Part B only): The suggested 
range of awards for local applicants is $250,000 to $450,000.
    Additional Information on Funding for all Applicants for Part A, 
Part B, and Part C New awards are expected to begin on or about July 1, 
2000, and are made for 12-month budget periods within project periods 
not to exceed 2-years for local programs or 3-years for State programs. 
Estimates outlined above are subject to change based on the actual 
availability of funds and the scope and quality of applications 
received. Continuation awards within the project period will be made on 
the basis of satisfactory progress and availability of funds. Awards 
cannot supplant existing funding for CLPP or Supplemental Funding 
Initiatives. Funds should be used to enhance the level of expenditures 
from State, local, and other funding sources.

    Note: Funds may not be expended for medical care and treatment 
or for environmental remediation of sources of lead exposure. 
However, the applicant must provide a plan to ensure that these 
program activities are carried out.

    Not more than 10 percent (exclusive of Direct Assistance) of any 
cooperative agreement or contract through the cooperative agreement may 
be obligated for administrative costs. This 10 percent limitation is in 
lieu of, and replaces, the indirect cost rate.

D. Program Requirements

    Special Requirement regarding Medicaid provider status of 
applicants: Pursuant to section 317A of the Public Health Service Act 
(42 U.S.C. 247b-1), as amended by Sec. 303 of the ``Preventive Health 
Amendments of 1992'' (Public Law 102-531), applicants AND current 
grantees must meet the

[[Page 6609]]

following requirements: For CLPP program services which are Medicaid-
reimbursable in the applicant's State:
    Applicants who directly provide these services must be enrolled 
with their State Medicaid agency as Medicaid providers.
    Providers who enter into agreements with the applicant to provide 
such services must be enrolled with their State Medicaid agency as 
providers. An exception to this requirement will be made for providers 
whose services are provided free of charge and who accept no 
reimbursement from any third-party payer. Such providers who accept 
voluntary donations may still be exempted from this requirement.
    In order to satisfy this program requirement, please provide a copy 
of a Medicaid provider certificate or Statement as proof that you meet 
this requirement. Failure to include this information would result in 
your application being returned. Please place this information 
immediately behind the budget and budget justification pages.

Cooperative Activities

Part A and Part B: New and Competing Continuations

    To achieve the purpose of this cooperative agreement program, the 
recipient will be responsible for the activities listed under 1. 
Recipient Activities and CDC will be responsible for the activities 
listed under 2. CDC Activities.
1. Recipient Activities
    a. Establish, maintain, or enhance a Statewide surveillance system 
in accordance with CDC guidance. For local applicants (under Part B), 
enhance a data management system that links with the State's 
surveillance system or develop an automated data management system to 
collect and maintain laboratory data on the results of blood lead 
analyses and data on follow-up care for children with elevated BLLs. 
State recipients should ensure receipt of data from local programs. 
Local recipients should transfer relevant data to the appropriate State 
entity in a timely manner for annual submission to CDC.
    b. Manage, analyze and interpret individual State surveillance 
data, and present and disseminate trends and other important public 
health findings.
    c. Develop, implement and evaluate a Statewide/jurisdiction-wide 
childhood blood lead screening plan consistent with CDC guidance 
provided in ``Screening Young Children for Lead Poisoning: Guidance for 
State and Local Public Health Officials''. For local applicants, 
participate in the Statewide planning process. Make screening 
recommendations and appropriate local screening strategies available 
and known to health care providers.
    d. Assure appropriate follow-up care is provided for children 
identified with elevated blood lead levels.
    e. Establish effective, well-defined working relationships within 
public health agencies and with other agencies and organizations at 
national, State, and community levels (e.g., housing authorities; 
environmental agencies; maternal and child health programs; State 
Medicaid Early Periodic Screening, Diagnosis, and Treatment (EPSDT) 
programs; community and migrant health centers; community-based 
organizations providing health and social services in or near public 
housing units, as authorized under Section 330(i) of the PHS Act; State 
and local epidemiology programs; State and local housing rehabilitation 
programs; schools of public health and medical schools; and 
environmental interest groups).
    f. For State Programs, provide managerial, technical, analytical, 
and program evaluation assistance to local agencies and organizations 
in developing or strengthening their CLPP programs activities.
2. CDC Activities
    a. Provide technical, and scientific assistance and consultation on 
program development, implementation and operational issues.
    b. Provide technical assistance and scientific consultation 
regarding the development and implementation of all surveillance 
activities including data collection methods and analysis of data.
    c. Assist with data analysis and interpretation of individual State 
surveillance data and release of national reports. Reports will include 
analysis of national aggregate data as well as State-specific data.
    d. Assist cooperative agreement recipients with communication and 
coordination among Federal agencies, and other public and private 
agencies and organizations.
    e. Conduct ongoing assessment of program activities to ensure the 
use of effective and efficient implementation strategies.

Part C: Supplemental Studies

    To achieve the purpose of this program, the recipient will be 
responsible for the activities listed under 1. Recipient Activities and 
CDC will be responsible for the activities listed under 2. CDC 
Activities.
1. Recipient Activities
    a. Develop and implement a study protocol to include the following: 
methodology, sample selection, field operation, and statistical 
analysis. Applicants must provide a means of assuring that the results 
of the study will be published.
    b. Revise, refine, and carry out the proposed methodology for 
conducting Supplemental Funding Studies.
    c. Monitor and evaluate all aspects of the assessment activities.
    d. Conduct and evaluate public health programs and/or have access 
to professionals who are knowledgeable in conducting such activities.
2. CDC Activities
    a. Provide technical and scientific consultation on activities 
related to overall program requirements of supplemental funding 
activities.
    b. Provide technical assistance to program manager and/or principal 
investigator regarding revision, refinement, and implementation of 
study design and proposed methodology for conducting supplemental 
funding activities.
    c. Assist program manager and/or principal investigator with data 
interpretation and analysis issues.

E. Application Content

    Use the information in the Program Requirements, Other 
Requirements, and Evaluation Criteria sections to develop the 
application content. Your application will be evaluated on the criteria 
listed, so it is important to follow them in laying out your program 
plan:
    Applications must be developed in accordance with PHS Form 5161-1.
    Part B applicants also competing for Part C funds must submit 
separate applications.
    Application pages must be clearly numbered, and a complete index to 
the application and its appendices must be included. The original and 
two copies of the application set must be submitted UNSTAPLED and 
UNBOUND. All material must be typewritten, double spaced, printed on 
one side only, with unreduced font (10 or 12 point font only) on 8\1/
2\" by 11" paper, and at least 1" margins and heading and footers. All 
graphics, maps, overlays, etc., should be in black and white and meet 
the above criteria.
    A one-page, single-spaced, typed abstract must be submitted with 
the application. The heading should include the title of the program, 
project title, organization, name and address, project director, 
telephone number, facsimile number, and e-mail address.

[[Page 6610]]

    The main body of the CLPP program application (Parts A or B) must 
include the following: budget/budget justification; Medicaid 
certification; progress report (Part B applicants only); understanding 
the problem; surveillance/data-management activities; Statewide/
jurisdiction-wide planning and collaboration; core public health 
functions; goals and objectives; program management and staffing; and 
program evaluation.
    The main body of the supplemental funding project application (Part 
C) must include the following: study protocol, project personnel, and 
project management.
    Each application should not exceed 75 pages. The abstract, budget 
narrative, and budget justification pages are not included in the 75 
page limit. Supplemental information should be placed in appendices and 
is not to exceed 25 pages.
    Part B applicants must submit a progress report no longer than 10 
pages in their competing continuation application. This report should 
be placed immediately after the budget and budget justification.
    Provide qualified staff, other resources, and knowledge to 
implement the provisions of the program. Applicants requesting 
cooperative agreement supported positions must provide assurances that 
such positions will be authorized to be filled by the applicant's 
personnel system.

F. Submission and Deadline

    Submit the original and two copies of the PHS 5161-1 (OMB Number 
0937-0189) on or before April 12, 1999. Forms are in the application 
kit.
    Submit the application to: Mattie B. Jackson, Grants Management 
Specialist, Grants Management Branch, Procurement and Grants Office, 
Program Announcement 00033, Centers for Disease Control and Prevention 
(CDC), 2920 Brandywine Road, Room 3000, Atlanta, GA 30341-4146.
    Applications shall be considered as meeting the deadline if they 
are either: (1) Received on or before the deadline date, or (2) sent on 
or before the deadline date and received in time for submission for the 
review process. Applicants must request a legibly dated receipt from a 
commercial carrier or U.S. Postal Service. Private metered postmarks 
shall not be acceptable as proof of timely mailing.
    Applications which do not meet the criteria above are considered 
late applications. Late applications will not be considered in the 
current competition and will be returned to the applicant.

G. Evaluation Criteria

    The review of applications will be conducted by an objective review 
panel as they relate to the applicant's response to either Part A, Part 
B, or Part C. The applications will be evaluated according to the 
following criteria:

Part A: New Applicants

1. Understanding of the Problem (15 points)
    The extent to which the applicant's description and understanding 
of the burden and distribution of childhood lead exposure or elevated 
BLLs in their jurisdiction, using evidence (as available) of incidence 
and/or prevalence and demographic indicators, including a description 
of the Medicaid population.
2. Surveillance Activities (20 points)
    The applicant's ability to develop a childhood blood lead 
surveillance system that includes; (a) a flow chart that describes data 
transfer, (b) a mechanism for tracking lead screening services to 
children, especially Medicaid children, and (c) a mechanism for 
reporting data annually to the CDC's national surveillance database. 
The clarity, feasibility, and scientific soundness of the surveillance 
approach. Also, the extent to which the proposed time table for 
accomplishing each activity and methods for evaluating each activity 
are appropriate and clearly defined. The following elements will be 
specifically evaluated:
    a. How laboratories report Blood Lead Levels (BLLs), including 
ability to identify and assure reporting from private laboratories 
which perform lead testing.
    b. How data will be collected and managed.
    c. How quality of data and completeness of reporting will be 
assured.
    d. How and when data will be analyzed.
    e. How summary data will be reported and disseminated on a regular 
basis (i.e., newsletters, fact sheets, annual reports).
    f. Protocols for follow-up of individuals with elevated BLLs.
    g. Provisions to obtain denominator data (results of all laboratory 
blood lead tests, regardless of level).
    h. Time line and methods for evaluating the Childhood Blood Lead 
Surveillance (CBLS) approach.
    i. Plans to convert paper-based components of the system to 
electronic data manipulation.
    j. Use of data including evaluation of prevention activities, 
especially to target screening and prevention efforts.
3. Statewide Planning and Collaboration (20 points)
    The applicant's ability to develop Statewide screening 
recommendations with appropriate local strategies. The following 
elements will be specifically evaluated:
    a. The proposed approach to developing and carrying out an 
inclusive Statewide screening plan as outlined in ``Screening Young 
Children for Lead Poisoning: Guidance for State and Local Health 
Officials''.
    b. The extent to which the applicant plans to utilize surveillance 
and program data to produce a Statewide screening recommendation, with 
specific attention given to the Medicaid population.
    c. The ability of the applicant to involve collaborators in the 
development of a screening plan and implementation of strategies to 
strengthen childhood lead poisoning prevention activities.
    d. The applicant's demonstrated ability to collaborate with 
principal partners, including managed-care organizations, State 
Medicaid agency, child health-care providers and provider groups, 
insurers, community-based organizations, housing agencies, and banking, 
real estate, and property-owner interests, must be demonstrated by 
letters of support, memoranda of understanding, contracts, or other 
documented evidence of relationships.
4. Capacity To Carry Out Public Health Core Functions (10 points)
    The applicant's ability to describe the approach and activities 
necessary to achieve a balance among health department roles in CLPP, 
including assessment, program and policy development, and monitoring, 
evaluating, and ensuring the provision of all necessary components of a 
comprehensive CLPP activities within their respective categories.
5. Goals and Objectives (15 points)
    The extent to which the applicant's goals and objectives relate to 
the CLPP activities in their respective categories. Objectives must be 
relevant, specific, measurable, achievable, and time-framed. There must 
be a formal work plan with a description of methods, a timetable and 
program staff responsible for accomplishment of each objective, and the 
evaluation of each proposed objective.
6.  Project Management and Staffing (10 points)
    The extent to which the applicant has documented the skills and 
ability to develop and carry out a comprehensive

[[Page 6611]]

CLLP program. Specifically, the applicant should:
    a. Describe the proposed health department staff roles in CLPP, 
their specific responsibilities, and their level of effort and time. 
Include a plan to expedite filling of all positions and assure that 
requested positions have been or will be approved by applicant's 
personnel system.
    b. Describe the plan to provide training and technical assistance 
to health department personnel and consultation to collaborators 
outside the health department, including proposed design of 
information-sharing systems.
7. Program Evaluation (10 points)
    The extent to which the applicant proposes to measure the overall 
impact of health department CLPP activities. Specific criteria should 
include:
    a. The plan for evaluating the impact or outcome of CLPP 
activities, including evaluation design, methods, and activities.
    b. Description of how the project will assess changes in public 
policy and measure the effectiveness of collaborative activities.
    c. Progress made in childhood lead poisoning prevention which 
resulted from planned health department strategies.
8. Budget justification (not scored)
    The extent to which the budget is reasonable, clearly justified, 
and consistent with the intended use of funds.

Part B: Competing Continuations

1. Understanding of the Problem (15 points)
    The extent to which the applicant's description and understanding 
of the burden and distribution of childhood lead exposure or elevated 
BLLs in their jurisdiction, using evidence (as available) of incidence 
and/or prevalence and demographic indicators, including a description 
of the Medicaid population.
2. Surveillance Activity (20 points)
    For State Applicants: The applicant's ability to expand its 
childhood blood lead surveillance system that includes tracking lead 
screening for Medicaid children, evaluating the existing system, and 
reporting data to the CDC's national surveillance database. The 
clarity, feasibility, and scientific soundness of the surveillance 
approach. Also, the extent to which the proposed time table for 
accomplishing each activity are appropriate and clearly defined. The 
following elements will be specifically evaluated:
    a. How laboratories report BLLs, including ability to identify and 
assure reporting from private laboratories which perform lead testing.
    b. How data are collected and managed.
    c. How quality of data and completeness of reporting are assured.
    d. How and when data are analyzed.
    e. How summary data are reported and disseminated on a regular 
basis (i.e., newsletters, fact sheets, annual reports).
    f. Protocols for follow-up of individuals with elevated BLLs.
    g. Provisions to obtain denominator data (results of all laboratory 
blood lead tests, regardless of level).
    h. Time line and methods for evaluating the Childhood Blood Lead 
Surveillance (CBLS) approach.
    i. Process used to convert paper-based components of the system to 
electronic data.
    j. Use of data including evaluation of prevention activities, 
especially to target screening and prevention efforts.
    For local applicants (Part B only): The applicant's ability to 
expand their data management system, including the approach to 
participating in the State CBLS, if applicable. The clarity, 
feasibility, and scientific soundness of the approach to data 
management. Also, the extent to which the proposed schedule for 
accomplishing each activity and method for evaluating each activity are 
clearly defined and appropriate. The following elements will be 
specifically evaluated:
    a. How laboratories report Blood Lead Levels (BLL), including 
ability to identify and assure reporting from private laboratories 
which perform lead testing.
    b. How data are collected and managed.
    c. How quality of data and completeness of reporting are assured.
    d. How and when data are analyzed.
    e. How summary data are reported and disseminated on a regular 
basis (i.e., newsletters, fact sheets, annual reports).
    f. Protocols for follow-up of individuals with elevated BLLs.
    g. Provisions to obtain denominator data (results of all laboratory 
blood lead tests, regardless of level).
    h. Time line and methods for evaluating the Childhood Blood Lead 
Surveillance (CBLS) approach.
    i. Process used to convert paper-based components of the system to 
electronic data.
    j. Use of data including evaluation of prevention activities, 
especially to target screening and prevention efforts.
3. Statewide/Jurisdiction-wide Planning and Collaboration (20 points)
    The applicant's ability to develop Statewide/jurisdiction-wide 
screening recommendations with appropriate local strategies. The 
following elements will be specifically evaluated:
    a. The approach to developing and carrying out an inclusive State-
or jurisdiction-wide screening plan as outlined in ``Screening Young 
Children for Lead Poisoning: Guidance for State and Local Health 
Officials''.
    b. The extent to which the applicant utilized surveillance and 
program data to produce Statewide/jurisdiction-wide screening 
recommendations and target the Medicaid population.
    c. Description of how collaborations facilitated the development of 
a screening plan and strengthened childhood lead poisoning prevention 
strategies.
    d. Evidence of collaboration with principal partners, including 
managed-care organizations, State Medicaid agency, child health-care 
providers and provider groups, insurers, community-based organizations, 
housing agencies, and banking, real-estate, and property-owner 
interests. These collaborations must be demonstrated by letters of 
support, memoranda of understanding, contracts, or other documented 
evidence of relationships.

    Note: For applicants under Part B, describe progress in 
developing and implementing the screening plan based upon each of 
the elements listed above.

4. Capacity to Carry Out Public-Health Core Functions (10 points)
    The ability to describe the approach and activities taken to 
achieve a balance among health-department roles in CLPP, including 
assessment, program and policy development, and monitoring, evaluating, 
and ensuring the provision of all CLPP activities within their 
respective categories (for example, Category 3 requires screening 
plans, surveillance systems, assure follow-up care, and evaluation).
5. Goals and Objectives (10 points)
    The extent to which the applicant's goals and objectives relate to 
the CLPP activities in their respective categories under which they 
applied. Objectives must be relevant, specific, measurable, achievable, 
and time-framed. There must be a formal work plan with a description of 
methods and a timetable and program staff responsible for 
accomplishment of each objective.

[[Page 6612]]

6. Project Management and Staffing (10 points)
    The extent to which the applicant has the skills and ability to 
develop and carry out a comprehensive CLLP program. Specifically the 
applicant should:
    a. Describe the proposed health department staff roles in CLPP, 
their specific responsibilities, and their level of effort and time. 
Include a plan to expedite filling of all positions and assure that 
requested positions have been or will be approved by the applicant's 
personnel system.
    b. Describe the plan to provide training and technical assistance 
to health department personnel and consultation to collaborators 
outside the health department, including proposed design of 
information-sharing systems.
7. Program Evaluation (10 points)
    The extent to which the applicant measures the overall impact of 
health department CLPP activities. Specific criteria should include:
    a. Description of the progress made to evaluate the impact and 
outcome of collective CLPP activities, including the evaluation design, 
methods, and tasks.
    b. Description of the changes in the effectiveness of collaborative 
activities.
    c. Progress made in childhood lead poisoning prevention which 
resulted from planned health department strategies.
8. Budget Justification (not scored)
    The extent to which the budget is reasonable, clearly justified, 
and consistent with the intended use of funds.

Part C: Supplemental Funding--Factors To Be Considered

1. Study Protocol (45 points)
    The applicant's ability to develop a scientifically sound protocol 
(including adequate sample size with power calculations), quality, 
feasibility, consistency with project goals, and soundness of the 
evaluation plan (which should provide sufficient detail regarding the 
way the protocol will be implemented). The degree to which the 
applicant has met the CDC policy requirements regarding the inclusion 
of women, ethnic, and racial groups in the proposed project. This 
includes: (a) the proposed plan to include of both sexes and racial and 
ethnic minority populations for appropriate representation; (b) the 
proposed justification when representation is limited or absent; (c) a 
Statement as to whether the design of the study is adequate to measure 
differences when warranted; and (d) a Statement as to whether the plans 
for recruitment and outreach for study participants includes 
establishing partnerships with community-based agencies and 
organizations. Benefits of the partnerships should be described.
2. Project Personnel (20 points)
    The extent to which personnel involved in this project are 
qualified, including experience in conducting relevant studies. In 
addition, the applicant's ability to commit appropriate staff time 
needed to carry out the study.
3. Project Management (35 points)
    The applicant's ability to implement and monitor the proposed study 
to include specific, attainable, and realistic goals and objectives, 
and evaluation plan.
4. Budget Justification (not scored)
    The extent to which the budget is reasonable, clearly justified, 
and consistent with the intended use of cooperative agreement funds.
5. Human Subjects (not scored)
    The extent to which the applicant complies with the Department of 
Health and Human Services regulations (45 CFR Part 46) on the 
protection of human subjects.

H. Other Requirements

Technical Reporting Requirements

    Provide CDC with the original plus two copies of:
    1. Quarterly progress reports, which are required of all grantees. 
The quarterly report narrative should not exceed 25 pages. Time lines 
for the quarterly reports will be established at the time of award, but 
are typically due 30 days after the end of each quarter.
    2. Calendar year surveillance data and a written surveillance 
summary report must be submitted annually to CDC in the approved OMB 
format to be disseminated to State and local public health officials 
and congressional personnel. Data must be submitted to CDC by March 
31st in the required format for analysis.
    3. Financial Status Reports, are due within 90 days of the end of 
the budget period.
    4. Final financial reports and performance reports are due within 
90 days after the end of the project period.
    Send all reports to the Grants Management Specialist identified in 
the ``Where to Obtain Additional Information'' section of this 
announcement.

    Note:
    Data collection initiated under this cooperative agreement program 
has been approved by the Office of Management and Budget under OMB 
number (0920-0337), ``National Childhood Blood Lead Surveillance 
System'', Expiration Date: March 31, 2001.

    The following additional requirements are applicable to this 
program. For a complete description of each, see Addendum 1 in the 
application package.

AR-1  Human Subjects Requirement
AR-2  Requirements for Inclusion of Women and Racial and Ethnic 
Minorities in Research
AR-7  Executive Order 12372 Review
AR-9  Paperwork Reduction Act Requirements
AR-10  Smoke-Free Workplace Requirements
AR-11  Healthy People 2000
AR-12  Lobbying Restrictions

I. Authority and Catalog of Federal Domestic Assistance Number

    This program is authorized under sections 301(a), 317A and 317B of 
the Public Health Service Act [42 U.S.C. 241(a), 247b-1, and 247b-3], 
as amended. Program regulations are set forth in Title 42, Code of 
Federal Regulations, Part 51b. The Catalog of Federal Domestic 
Assistance number is 93.197.

J. Pre-Application Workshop for New and Competing Continuation 
Applicants

    In addition, for interested applicants, a telephone conference call 
for pre-application technical assistance will be held on Wednesday, 
February 16, 2000, from 1:30 p.m. to 3:30 p.m, Eastern Standard Time. 
The bridge number for the conference call is 1-800-311-3437, and the 
pass code is 350892. For further information about all workshops, 
please contact Claudette Grant-Joseph at 404-639-2510.

K. Where To Obtain Additional Information

    This and other CDC announcements may be downloaded through the CDC 
homepage on the Internet at http://www.cdc.gov. Please refer to program 
announcement number 00033 when requesting information. To receive 
additional written information and to request an application kit, call 
1-888-GRANTS4 (1-888-472-6874). You will be asked to leave your name, 
address, and phone number and will need to refer to Announcement 00033. 
You will receive a complete program description, information on 
application procedures, and application forms. CDC will not send 
application kits by facsimile or express mail.

[[Page 6613]]

    If you have questions after reviewing the contents of all 
documents, business management technical assistance may be obtained 
from: Mattie B. Jackson, Grants Management Specialist, Grants 
Management Branch, Procurement and Grants Office, Centers for Disease 
Control and Prevention (CDC), 2920 Brandywine Road, Room 3000, Atlanta, 
GA 30341-4146, telephone (770) 488-2718, Internet address <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="cda0a4a7fee38daea9aee3aaa2bb">[email protected]</a>
    For programmatic technical assistance, contact: Claudette A. Grant-
Joseph, Chief, Program Services Section, Lead Poisoning Prevention 
Branch, Division of Environmental Hazards and Health Effects, National 
Center for Environmental Health, Centers for Disease Control and 
Prevention (CDC), 1600 Clifton Road, NE, Mailstop E-25, Atlanta, GA 
30333, telephone (404) 639-2510, Internet address <a href="/cdn-cgi/l/email-protection#f5969492c1b5969196db929a83"><span class="__cf_email__" data-cfemail="a0c3c1c794e0c3c4c38ec7cfd6">[email protected]</span></a>

    Dated: February 4, 2000.
John L. Williams,
Director, Procurement and Grants Office, Centers for Disease Control 
and Prevention (CDC).
[FR Doc. 00-3062 Filed 2-9-00; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>